⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001216489

LACASSE LOUIS P

Reports to the SEC for 2 companies · SAN DIEGO, CA

Transactions

8

Companies

2

Filings

4

CIK

0001216489

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-06-11	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2013-07-30	Histogen Inc.C Conversion	Director	CConversion	+673K sh	—	—	673,400
2013-07-30	Histogen Inc.J Other	Director	JOther	+12.5K sh	$11.00	+$138K	685,937
2013-07-30	Histogen Inc.P Purchase	Director	PPurchase	+124K sh	$11.00	+$1.36M	809,887
2013-07-30	Histogen Inc.Series B Preferred StockC Conversion	Director	CConversion	−5.56M sh	—	—	0
2013-07-30	Histogen Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2005-05-26	ARMPArmata Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2004-05-20	ARMPArmata Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

4

Accepted (ET)
Jun 154
Conatus Pharmaceuticals Inc.0001209191-15-053230
SEC(opens sec.gov)
Aug 14
Conatus Pharmaceuticals Inc0001209191-13-038811
SEC(opens sec.gov)
May 264
TARGETED GENETICS CORP /WA/0001209191-05-028540
SEC(opens sec.gov)
May 244
LACASSE LOUIS P0001209191-04-027448
SEC(opens sec.gov)

Companies

2

Address

C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE, SUITE 200

SAN DIEGO, CA, 92121